期刊文献+

喉癌患者凝血、纤溶指标及血小板参数检测的临床意义 被引量:4

Clinical significance of detection of blood coagulation,fibrinolysis and platelet parameter in patients with laryngeal carcinoma
下载PDF
导出
摘要 目的探讨凝血、纤溶指标及血小板参数与喉癌临床分期及转移的关系。方法选取155例喉癌患者作为喉癌组,选择同期住院的80例喉部良性疾病患者作为对照组,检测2组入院次日晨起凝血酶原时间(PT)、活化部分凝血酶原时间(APTT)、纤维蛋白原(Fib)、D-二聚体(D-dimer)以及血小板计数(Plt)、血小板压积(PCT)、血小板分布宽度(PDW)、血小板分布体积(MPV),分析喉癌组各指标水平与喉癌临床分期、有无转移、病理分化程度的关系。结果喉癌组Fib、D-dimer水平均明显高于对照组(P均<0.05)。喉癌组中Ⅲ期、Ⅳ期喉癌患者Fib、D-dimer、Plt水平均明显高于Ⅰ期、Ⅱ期患者(P均<0.05);发生转移患者APTT明显短于未转移患者,Fib、D-dimer、Plt水平明显高于未转移患者,差异均有统计学意义(P均<0.05);不同分化程度喉癌患者各指标水平比较差异均无统计学意义(P均>0.05)。结论喉癌患者血液呈高凝状态,且存在继发纤溶亢进,这种凝血与纤溶系统改变与喉癌的临床分期及有无转移有关,与喉癌病理分化程度无关。 Objective It is to investigate the relationship of blood coagulation,fibrinolysis and platelet parameter with clinical staging and metastasis in patients with laryngeal carcinoma. Methods The indexes of prothrombin time( PT),activated partial thromboplastin time( APTT),fibrinogen( Fib),D- dimer,platelet count( Plt),platelet hematocrit( PCT),platelet distribution width( PDW) and mean platelet volune( MPV) were detected in 155 patients with laryngeal carcinoma in laryngeal group and 80 patients with laryngeal benign disease in control group. The relationship of these indexes with clinical stage,metastasis and pathological differentiation degree were analyzed. Results The indexes of Fib and D- dimer in laryngeal carcinoma group were higher than those in control group( all P 〈 0. 05). The indexes of Fib,D- dimer and Plt in Ⅲ,Ⅳ stage were higher than those in Ⅰ,Ⅱ stage( all P 〈 0. 05). The index of APTT in patients with metastasis was shorter than that without,and Fib,D- dimer and Plt in patients with metastasis higher than those without,There were significant difference in all indexes. There was no significant difference in all indexes among the disparity differentiation of laryngeal carcinoma. Conclusion The patients with laryngeal carcinoma are in hypercoagulable and secondary hyperfibrinolysis,which concerned with laryngeal carcinoma clinical stage and metastasis.
出处 《现代中西医结合杂志》 CAS 2015年第36期4003-4005,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
基金 河北省卫生厅科研基金项目(20150462)
关键词 喉癌 纤维蛋白原 D-二聚体 血小板计数 laryngeal carcinoma fibrinogen D-dimer platelet counts
  • 相关文献

参考文献10

  • 1陈本均,何茂兰,冉约曼,赵小卫.宫颈癌患者凝血指标与肿瘤临床病理特征的相关性研究[J].河北医学,2015,21(1):39-42. 被引量:9
  • 2王丽丽,徐成伟.恶性肿瘤血栓形成机制的研究进展[J].血栓与止血学,2013,19(5):237-240. 被引量:11
  • 3Bruyere F,Melen-Lamalle L,Blacher S,et al.Does plasminogen activator inhibitor-1 drive lymphangiogensis[J].PLo S One,2010,5(1):9653.
  • 4Hoffmann AC,Mori R,Vallbohmer D,et al.High expression of HIFLa is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDFA,VEGF and b-FGF[J].Neoplasia(New York),2008,10(7):674-679.
  • 5董伟达,李兆基,周水淼.喉癌患者手术前后凝血状态的动态观察[J].临床耳鼻咽喉科杂志,2001,15(6):258-260. 被引量:6
  • 6张月莉,梁红,沈维敏,朱砚萍,李向阳,朱惠莉,瞿介明.凝血指标与肺癌患者预后的关系[J].上海医学,2013,36(12):1031-1037. 被引量:11
  • 7Schoenleber SJ,Kurtz DM,Talwalkar JA,et al.Prognostic role of wascular endothelial growth factor in hepatocellular carcinoma:systematic review and meta analysis[J].Br J Cancer,2009,100(9):1385-1392.
  • 8Qiu J,Yu Y,Fu Y,et al.Preoperative plasma fibrinogen,platelet counted prognostic in epithelial ovarian cancer[J].J Obstet Gynaecol Res,2012,38(4):651-657.
  • 9Buery D,Wenz F,Groden C,at al.Tumor-platelet interaction in solid tumors[J].Cancer,2012,130(12):2747-2760.
  • 10Lee M,Kim SW,Nam EJ,et al.The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer[J].Gvnecol Oncol,2011,122(2):238-241.

二级参考文献72

  • 1白丽萍,门剑龙.恶性转移瘤患者高凝状态的研究[J].中国慢性病预防与控制,2006,14(4):241-242. 被引量:19
  • 2LEE AY, LEVINE MN. Venous thromboembolism and cancer: risks and outcomes [ J ]. Circulation,2003,107 : I- 17- I- 21.
  • 3KHORANA AA, FRANCIS CW, EVA CULAKOVA, et al. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients[J]. Cancer,2007,110(10) :2339-2346.
  • 4RICKLES FR,FALANGA A. Molecular basis for the relationship between thrombosis and cancer[ J ]. Thromb Res ,2001,102 ( 6 ) : V215- 22.
  • 5FALANGA A,OFOSU FA, CORTELAZZO S, et al. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery[J]. Br J Haematol,1993,85(4) :745-750.
  • 6AY C ,SIMANEK R,VORMITTAG R,et al. High plasma levels of soluble P- selectin are predictive of venous thromboembolism in cancer patients: results from the vienna cancer and thrombosis study (CATS) [ J ]. Blood,2008,112 (7) :2703- 2708.
  • 7AY C, VORMITTAG R, DUNKLER D, et al. D- dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the vienna cancer and thrombosis study [ J ]. J Clin Oncol,2009,27 (25) :4124-4129.
  • 8FALANGA A ,TARTARI C J, MARCHETTI M. Microparticles in tumor progression[J]. Thromb Res,2012,129( Suppl 1) :S132-136.
  • 9ZWICKER JI, LIEBMAN HA, NEUBERG D,et al. Tumor- derived tissue factor-bearing microparticles are associated with venous throm-boembolie events in malignancy[J]. Clin Cancer Res, 2009, 15 (22) : 6830- 6840.
  • 10HEIT JA,SILVERSTEIN MD, MOHR DN,et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study[J]. Arch Intern Med,2000,160(6):809-815.

共引文献31

同被引文献33

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部